PH31558A - Release controlled implantable somatotropin composition. - Google Patents
Release controlled implantable somatotropin composition.Info
- Publication number
- PH31558A PH31558A PH47531A PH47531A PH31558A PH 31558 A PH31558 A PH 31558A PH 47531 A PH47531 A PH 47531A PH 47531 A PH47531 A PH 47531A PH 31558 A PH31558 A PH 31558A
- Authority
- PH
- Philippines
- Prior art keywords
- release controlled
- somatotropin composition
- controlled implantable
- implantable
- somatotropin
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019920025904A KR100260632B1 (ko) | 1992-12-28 | 1992-12-28 | 이식형 소마토트로핀 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH31558A true PH31558A (en) | 1998-11-03 |
Family
ID=19347021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH47531A PH31558A (en) | 1992-12-28 | 1993-12-22 | Release controlled implantable somatotropin composition. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5662917A (zh) |
KR (1) | KR100260632B1 (zh) |
CN (1) | CN1093597A (zh) |
AU (1) | AU660119B2 (zh) |
BR (1) | BR9305261A (zh) |
MX (1) | MX9400148A (zh) |
PH (1) | PH31558A (zh) |
TW (1) | TW362020B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001512306A (ja) | 1997-01-08 | 2001-08-21 | ライフ テクノロジーズ,インコーポレイテッド | タンパク質の産生方法 |
US5807594A (en) * | 1997-02-26 | 1998-09-15 | Ducoa, L.P. | Method for enhancing feed efficiency in ruminants with an encapsulating choline composition |
KR19990071255A (ko) * | 1998-02-28 | 1999-09-15 | 성재갑 | 소마토트로핀과 비타민의 합제 조성물 |
AUPP279698A0 (en) * | 1998-04-03 | 1998-04-30 | Sunscape Developments Limited | Sustained release formulation |
WO2002013848A1 (en) * | 2000-08-11 | 2002-02-21 | Invitrogen Corporation | Highly homogeneous molecular markers for electrophoresis |
US20040014082A1 (en) * | 2000-08-11 | 2004-01-22 | Invitrogen Corporation | Highly homogeneous molecular markers for electrophoresis |
US7034037B2 (en) * | 2001-06-29 | 2006-04-25 | Ethicon, Inc. | Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin |
KR100838219B1 (ko) * | 2001-07-13 | 2008-06-13 | 동아제약주식회사 | 인간성장호르몬의 지속적인 방출이 가능한 생분해성약학적 조성물 및 미립구 제형 |
CA2454249A1 (en) | 2001-08-06 | 2003-02-20 | Southwest Research Institute | Method and apparatus for testing catalytic converter durability |
US7572298B2 (en) * | 2003-03-28 | 2009-08-11 | Ethicon, Inc. | Implantable medical devices and methods for making same |
KR20130024987A (ko) * | 2005-12-22 | 2013-03-08 | 노파르티스 아게 | 옥트레오티드 및 2종 이상의 폴리락티드-코-글리콜리드 중합체를 포함하는 서방형 제제 |
WO2010108299A1 (zh) * | 2009-03-25 | 2010-09-30 | Chen I-Huang | 可转换运动方式的健身装置 |
CN111714442B (zh) * | 2019-03-04 | 2024-04-12 | 广州铂思雅生物医药科技有限公司 | 植入剂的制备 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4765980A (en) * | 1986-04-28 | 1988-08-23 | International Minerals & Chemical Corp. | Stabilized porcine growth hormone |
CA1257199A (en) * | 1986-05-20 | 1989-07-11 | Paul Y. Wang | Preparation containing bioactive macromolecular substance for multi-months release in vivo |
US4837381A (en) * | 1986-08-11 | 1989-06-06 | American Cyanamid Company | Compositions for parenteral administration and their use |
US5219572A (en) * | 1989-03-17 | 1993-06-15 | Pitman-Moore, Inc. | Controlled release delivery device for macromolecular proteins |
AU634529B2 (en) * | 1989-03-17 | 1993-02-25 | Pitman-Moore, Inc. | Controlled release delivery device for macromolecular proteins |
WO1991005548A1 (en) * | 1989-10-10 | 1991-05-02 | Pitman-Moore, Inc. | Sustained release composition for macromolecular proteins |
US5225212A (en) * | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
US5091185A (en) * | 1990-06-20 | 1992-02-25 | Monsanto Company | Coated veterinary implants |
US5223268A (en) * | 1991-05-16 | 1993-06-29 | Sterling Drug, Inc. | Low solubility drug-coated bead compositions |
-
1992
- 1992-12-28 KR KR1019920025904A patent/KR100260632B1/ko not_active IP Right Cessation
-
1993
- 1993-12-22 PH PH47531A patent/PH31558A/en unknown
- 1993-12-23 AU AU52718/93A patent/AU660119B2/en not_active Ceased
- 1993-12-27 TW TW082111022A patent/TW362020B/zh active
- 1993-12-28 BR BR9305261A patent/BR9305261A/pt not_active Application Discontinuation
- 1993-12-28 CN CN93121466A patent/CN1093597A/zh active Pending
-
1994
- 1994-01-03 MX MX9400148A patent/MX9400148A/es not_active IP Right Cessation
-
1996
- 1996-03-22 US US08/601,275 patent/US5662917A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
TW362020B (en) | 1999-06-21 |
KR940013534A (ko) | 1994-07-15 |
US5662917A (en) | 1997-09-02 |
MX9400148A (es) | 1994-07-29 |
AU5271893A (en) | 1994-07-07 |
CN1093597A (zh) | 1994-10-19 |
BR9305261A (pt) | 1994-07-05 |
AU660119B2 (en) | 1995-06-08 |
KR100260632B1 (ko) | 2000-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA935569B (en) | Controlled release implants | |
GB9208339D0 (en) | Treatment composition | |
SG67347A1 (en) | Controlled release formulation | |
EP0598412A3 (de) | Hautschutzmittel zum Schutz der menschlichen Haut. | |
ZA913751B (en) | Controlled release composition | |
IL98040A0 (en) | Stabilized fgf composition | |
GB9111559D0 (en) | Polyisocyanate composition | |
ZA932057B (en) | Polyisocyanate composition | |
GB9004950D0 (en) | Controlled release formulation | |
PH31558A (en) | Release controlled implantable somatotropin composition. | |
GB2252043B (en) | Controlled release compositions | |
ZA936811B (en) | Somatotropin modifications | |
ZA942959B (en) | Controlled release formulation. | |
ZA931481B (en) | Implants. | |
HK1005596A1 (en) | Polyisocyanate composition | |
EP0586848A3 (de) | Implantat. | |
OA09237A (en) | Implant. | |
GB2267832B (en) | Prosthesis | |
GB8927635D0 (en) | Implant gun | |
EP0517527A3 (en) | Polyisocyanate composition | |
ZA893966B (en) | Controlled release composition | |
PH31066A (en) | Treatment composition. | |
GB9114985D0 (en) | Pyrotechnic composition | |
GB9201344D0 (en) | Implant | |
ZA921249B (en) | Bis-bibenzimidazole composition. |